Cited by 903Sirtuins and Resveratrol in MedicineMetabolism, Diabetes, and CancerAdipose Tissue and Metabolism

AMPK and SIRT1: a long-standing partnership?

Open access
Ruderman, Neil B., Julia Xu, X., Nelson, Lauren, Cacicedo, José M., Saha, Asish K., Lan, Fan, Ido, Yasuo·2010·American Journal of Physiology-Endocrinology and Metabolism

Abstract

AMP-activated protein kinase (AMPK) and the histone/protein deacetylase SIRT1 are fuel-sensing molecules that have coexisted in cells throughout evolution. When a cell's energy state is diminished, AMPK activation restores energy balance by stimulating catabolic processes that generate ATP and downregulating anabolic processes that consume ATP but are not acutely needed for survival. SIRT1 in turn is best known historically for producing genetic changes that mediate the increase in longevity caused by calorie restriction. Although the two molecules have been studied intensively for many years, only recently has it become apparent that they have similar effects on diverse processes such as cellular fuel metabolism, inflammation, and mitochondrial function. In this review we will examine the evidence that these similarities occur because AMPK and SIRT1 both regulate each other and share many common target molecules. In addition, we will discuss the clinical relevance of these interactions and in particular the possibility that their dysregulation predisposes to disorders such as type 2 diabetes and atherosclerotic cardiovascular disease and is a target for their therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1152/ajpendo.00745.2009

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [25]Gauthier MS, Bigornia S, Mott M, Gokce N, Apovian C, Ruderman NB. Decreased AMP-activated protein kinase activity is associated with markers of inflammation and infiltration of immune cells in visceral and subcutaneous adipose tissue, and with whole-body insulin resistance in obese patients (Abstract). Obesity (Silver Spring) 17: S93.(158-P), 2009 [Google Scholar]
  2. [98]Um JH, Park SJ, Kang H, Yang S, Foretz M, McBurney MW, Kim MK, Viollet B, Chung JH. AMPK-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes In press [DOI] [PMC free article] [PubMed] [Google Scholar]

Cited by

Sorted by citations

Authors
Ruderman, N. B., Julia Xu, X., Nelson, L., Cacicedo, J. M., Saha, A. K., Lan, F., & Ido, Y.
Affiliations
  • Boston University (US)
  • Diabetes Research Unit, Section of Endocrinology, Departments of Medicine, Physiology, and Biophysics, Boston University School of Medicine and Boston Medical Center, Boston, Massachusetts
Corresponding author
Ruderman, Neil B.
Venue
American Journal of Physiology-Endocrinology and Metabolism
Published
2010-04
Volume
298
Issue
4
Pages
E751-E760
ISSN
  • 0193-1849 (ISSN-L)
  • 1522-1555
OpenAlex
W2140406095
Cited by
903
References
112
Citations by year
2026: 52 · 2025: 57 · 2024: 56 · 2023: 59 · 2022: 84 · 2021: 80 · 2020: 75 · 2019: 53 · 2018: 53 · 2017: 54 · 2016: 46 · 2015: 50 · 2014: 53 · 2013: 45 · 2012: 39
FWCI
3.62
Type
journal article
Language
en
Open access
Locations
  • American Journal of Physiology-Endocrinology and Metabolism (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Diabetes Association
  • National Institutes of Health (5r01dk019514-35)
  • National Heart, Lung, and Blood Institute (P01HL068758)
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007201, R01DK067509, R01-DK-019514)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
Keywords
AMPK, SIRT1, energy sensing, fuel metabolism, caloric restriction, longevity, inflammation, mitochondrial function, type 2 diabetes, atherosclerotic cardiovascular disease, therapeutic target
MeSH terms
Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Enzyme Activation, Humans, Gene Expression Regulation, Enzymologic, Cyclic AMP-Dependent Protein Kinases, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review